Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Resmed Inc (RMD)

Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Resmed Inc 9001 SPECTRUM CENTER BLVD. SAN DIEGO CA 92123 USA

www.resmed.co.in Employees: 10,600 P: 858-836-5000

Sector:

Medical

Description:

ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.

Key Statistics

Overview:

Market Capitalization, $K 37,441,160
Enterprise Value, $K 36,890,100
Shares Outstanding, K 145,941
Annual Sales, $ 5,146 M
Annual Net Income, $ 1,401 M
Last Quarter Sales, $ 1,336 M
Last Quarter Net Income, $ 348,540 K
EBIT, $ 1,792 M
EBITDA, $ 2,028 M
60-Month Beta 0.87
% of Insider Shareholders 0.65%
% of Institutional Shareholders 54.98%
Float, K 144,992
% Float 99.35%
Short Volume Ratio 0.71

Growth:

1-Year Return 4.73%
3-Year Return 16.78%
5-Year Return 25.43%
5-Year Revenue Growth 74.04%
5-Year Earnings Growth 100.63%
5-Year Dividend Growth 35.90%

Per-Share Information:

Most Recent Earnings 2.55 on 10/30/25
Next Earnings Date 01/29/26
Earnings Per Share ttm 9.90
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 15.91%
Annual Dividend & Yield 2.26 (0.88%)
Annual Dividend & Yield (Fwd) 2.40 (0.95%)
Most Recent Dividend 0.600 on 11/13/25
Next Ex-Dividends Date 11/13/25
Dividend Payable Date 12/18/25
Dividend Payout Ratio 22.03%
Most Recent Split 2-1 on 08/31/10

RMD Ratios

Ratio
Price/Earnings ttm 25.41
Price/Earnings forward 23.27
Price/Earnings to Growth 1.70
Return-on-Equity % 25.45%
Return-on-Assets % 18.68%
Profit Margin % 27.22%
Debt/Equity 0.07
Price/Sales 7.13
Price/Cash Flow 22.45
Price/Book 6.00
Book Value/Share 41.94
Interest Coverage 407.17

RMD Dividends

Date Value
11/13/25 $0.6000
08/14/25 $0.6000
05/08/25 $0.5300
02/13/25 $0.5300
11/07/24 $0.5300
08/15/24 $0.5300
05/08/24 $0.4800
02/07/24 $0.4800
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar